Research Article

MicroRNA Expression Profiling in PBMCs: A Potential Diagnostic Biomarker of Chronic Hepatitis C

Table 4

The association of the targets miRNAs expression levels and clinical factors (such as ALT, AST, and liver fibrosis) of the CHC patients.

ParametersmiR-193b miR-199a-3pmiR-122miR-16miR-214miR-222miR-324-3p

ALT
 <40 U/L0.169 ± 0.838777.105 ± 2178.0700.003 ± 0.01021.762 ± 69.40518.220 ± 65.5770.425 ± 0.9547.771 ± 39.245
 ≧40 U/L0.214 ± 1.4641113.280 ± 497.2650.001 ± 0.002212.344 ± 504.98954.410 ± 200.4813.425 ± 11.77026.781 ± 67.231
value0.0010.009<0.0001<0.00010.235<0.00010.001
AST
 <40 U/L0.027 ± 0.005426.223 ± 1115.8700.003 ± 0.01213.217 ± 40.28317.412 ± 64.8510.496 ± 1.13511.157 ± 48.112
 ≧40 U/L0.174 ± 1.297882.580 ± 436.0440.001 ± 0.003168.314 ± 445.08745.757 ± 177.1392.631 ± 10.24420.214 ± 58.935
value<0.0001<0.0001<0.0001<0.00010.760<0.00010.001
Liver cirrhosis
 No0.228 ± 1.410964.452 ± 454.5440.017 ± 0.122197.502 ± 490.549150.749 ± 891.3452.529 ± 5.82145.846 ± 209.718
 Yes0.012 ± 0.0291340.147 ± 440.1600.001 ± 0.003109.524 ± 243.19040.417 ± 79.6566.452 ± 19.40634.221 ± 86.321
value0.2210.8000.8660.9960.0540.5840.508

AST: aspartate aminotransferase; ALT: alanine aminotransferase.